Functions of mammalian PGLYRPs in the cornea
Functions of mammalian PGLYRPs in the cornea
批准号:
8241901
负责人:
Shukti Chakravarti
金额:
$20.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-04-01 至 2014-03-31
关键词:
AffectAgeAmidohydrolasesAnti-Bacterial AgentsBacteriaBacterial InfectionsBiological AssayBiologyCell Culture TechniquesCellsClinicalContact LensesCorneaCorneal InjuryDebridementDefense MechanismsDefensinsEnzyme-Linked Immunosorbent AssayEpithelialEpithelial CellsEyeFutureGenesHealedHealthHomeostasisHumanImmuneImpaired wound healingIn VitroInfectionInflammationInflammatoryInjuryInsectaKeratitisKnock-outKnockout MiceLeadLettersLigandsLungModelingMolecularMusMutant Strains MiceNatural ImmunityNuclearOperative Surgical ProceduresOutcomePathway interactionsPeptidesPeptidoglycanProtein FamilyProteinsPseudomonasPseudomonas aeruginosaRegulationReportingResearchRiskRoleSignal TransductionSmall Interfering RNATLR2 geneTLR4 geneTestingTherapeuticToll-Like Receptor 2TransplantationTraumaVisionWorkamidaseantimicrobialantimicrobial peptidebactericidebasecorneal epitheliumcytokineexperiencehealingimprovedin vivokillingslumicanmembermigrationmouse modelnatural antimicrobialpathogenpathogenic bacteriapeptidoglycan recognition proteinprophylacticpublic health relevancereceptorresponseskillswound
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The cornea is a transparent, refractive, protective mucosal barrier of the eye. Corneal infections pose a serious threat to healthy vision. Risks of infections increase with injury, surgery, daily contact lens wear and age. Research on antimicrobial proteins and peptides is critical for elucidating natural protective mechanisms in the cornea and therapies based on these. Our proposal focuses on the mammalian peptidoglycan recognition protein (PGLYRP) family of four antimicrobial proteins, which exist in various mucosal barriers, and identified just over a decade ago. We found PGLYRP1, and subsequently others PGLYRP2, -3 and -4 in the human and mouse cornea. Functions of mammalian PGLYRP members are generally underexplored, and in particular little is known of these in the eye. Much more is known of the large PGLYRP family in insects: they are mostly bactericidal, some hydrolyze peptidoglycans (PGN) to restrict inflammation, while others signal to host toll and imd pathways to induce genes of innate immunity and antimicrobial peptides (AMP). Mammalian PGLYRP1, - 3 and -4 are bactericidal against gram positive and negative bacteria, and PGLYRP2 is an amidase. In vitro, they work synergistically with AMPs, synergy in vivo is not known, but suspected. Whether the mammalian PGLYRPs also modulate innate immune signals remains to be fully investigated.. Thus, the mammalian PGLYRPs may represent a new class of antimicrobial immune modulators in the cornea. Our central hypothesis in this R21 proposal is that PGLYRPs in the mammalian cornea may have a dual role in deterring pathogenic bacterial infections while promoting innate immune signals for corneal healing and homeostasis. Two aims will test this central hypothesis.1) Test antibacterial defense capabilities of Pglyrp1-4 null mice in a Pseudomonas (P).aeruginosa keratitis model. 2a)Test if the PGLYRPs cross talk with innate immune signals (TLR2, 4 and Nod2) in the cornea to up regulate cytokines and b- defensins, and 2b) whether the PGLYRPs expedite corneal healing by promoting epithelial migration. This exploratory study of the PGLYRP family will provide the necessary assessment of its role in the cornea and the groundwork for future detailed studies of each member in promoting corneal health, curbing infections and developing targeted therapies. In the future our study may lead to prophylactic or therapeutic approaches that tweak PGLYRP levels in the corneal epithelium before/after surgery, infection and storage of transplant corneas.
PUBLIC HEALTH RELEVANCE: Our findings on this peptidoglycan recognition protein family will elucidate natural antimicrobial defense mechanisms in the cornea, therapeutic/prophylactic strategies for regulating their levels and functions during corneal infections and injury or surgery-related trauma, transplant cornea or contact lens storage.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of NBEAL2 in the cornea
-
批准号:10322135
-
项目类别:
-
资助金额:$24.66万
-
财政年份:2021
-
负责人:Shukti Chakravarti
-
依托单位:
Extracellular matrix proteoglycans regulate toll-like receptors 4 and 9
-
批准号:10329965
-
项目类别:
-
资助金额:$39.77万
-
财政年份:2020
-
负责人:Shukti Chakravarti
-
依托单位:
Extracellular matrix proteoglycans regulate toll-like receptors 4 and 9
-
批准号:10563132
-
项目类别:
-
资助金额:$41.0万
-
财政年份:2020
-
负责人:Shukti Chakravarti
-
依托单位:
Extracellular matrix proteoglycans regulate toll-like receptors 4 and 9 - Equipment Supplement
-
批准号:10848823
-
项目类别:
-
资助金额:$4.52万
-
财政年份:2020
-
负责人:Shukti Chakravarti
-
依托单位:
Cellular and Genetic Defects in Keratoconus
-
批准号:10584762
-
项目类别:
-
资助金额:$62.51万
-
财政年份:2016
-
负责人:Shukti Chakravarti
-
依托单位:
TGF beta and AKT signal-driven pathogenesis in keratoconus
-
批准号:9282779
-
项目类别:
-
资助金额:$57.96万
-
财政年份:2016
-
负责人:Shukti Chakravarti
-
依托单位:
Functions of mammalian PGLYRPs in the cornea
-
批准号:8093360
-
项目类别:
-
资助金额:$24.6万
-
财政年份:2011
-
负责人:Shukti Chakravarti
-
依托单位:
2010 Biology and Pathobiology of The Cornea
-
批准号:7795339
-
项目类别:
-
资助金额:$3.0万
-
财政年份:2010
-
负责人:Shukti Chakravarti
-
依托单位:
Extracellular matrix in pediatric IBD
-
批准号:6652808
-
项目类别:
-
资助金额:$14.71万
-
财政年份:2002
-
负责人:Shukti Chakravarti
-
依托单位:
Extracellular matrix in pediatric IBD
-
批准号:6496714
-
项目类别:
-
资助金额:$14.71万
-
财政年份:2001
-
负责人:Shukti Chakravarti
-
依托单位:
Extracellular matrix in pediatric IBD
-
批准号:6360311
-
项目类别:
-
资助金额:$14.71万
-
财政年份:2000
-
负责人:Shukti Chakravarti
-
依托单位:
LUMICAN AND EYE DEVELOPMENT AND FUNCTIONS
-
批准号:2856956
-
项目类别:
-
资助金额:$19.63万
-
财政年份:1997
-
负责人:Shukti Chakravarti
-
依托单位:
LUMICAN AND EYE DEVELOPMENT AND FUNCTIONS
-
批准号:6342654
-
项目类别:
-
资助金额:$22.29万
-
财政年份:1997
-
负责人:Shukti Chakravarti
-
依托单位:
Role of Lumican in the Cornea
-
批准号:6543698
-
项目类别:
-
资助金额:$32.7万
-
财政年份:1997
-
负责人:Shukti Chakravarti
-
依托单位:
The Role of Lumican in the cornea
-
批准号:8114033
-
项目类别:
-
资助金额:$38.97万
-
财政年份:1997
-
负责人:Shukti Chakravarti
-
依托单位:
The Role of Lumican in the cornea
-
批准号:7315007
-
项目类别:
-
资助金额:$41.0万
-
财政年份:1997
-
负责人:Shukti Chakravarti
-
依托单位:
The Role of Lumican in the Cornea
-
批准号:8630138
-
项目类别:
-
资助金额:$40.5万
-
财政年份:1997
-
负责人:Shukti Chakravarti
-
依托单位:
The Role of Lumican in the cornea
-
批准号:7686121
-
项目类别:
-
资助金额:$41.0万
-
财政年份:1997
-
负责人:Shukti Chakravarti
-
依托单位:
Role of Lumican in the Cornea
-
批准号:6769546
-
项目类别:
-
资助金额:$32.7万
-
财政年份:1997
-
负责人:Shukti Chakravarti
-
依托单位:
The Role of Lumican in the cornea
-
批准号:8302366
-
项目类别:
-
资助金额:$38.97万
-
财政年份:1997
-
负责人:Shukti Chakravarti
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: